Long-Term Effectiveness of Oral Ferric Maltol vs Intravenous Ferric Carboxymaltose for the Treatment of Iron-Deficiency Anemia in Patients With Inflammatory Bowel Disease: A Randomized Controlled Noninferiority Trial (vol 28, pg 373, 2022)
Por:
Howaldt, S, Domenech, E, Martinez, N, Schmidt, C and Bokemeyer, B
Publicada:
2 mar 2022
Resumen:
Filiaciones:
Howaldt, S:
Res Inst IBD HaFCED eK, Hamburg, Germany
:
Hosp Badalona Germans Trias & Pujol, Dept Gastroenterol & Hepatol, Badalona, Spain
Ctr Invest Biomed Red Enfermedades Hepat & Digest, Badalona, Spain
Martinez, N:
Gastroenterol Res Amer, San Antonio, TX USA
Schmidt, C:
Klinikum Fulda, Dept Gastroenterol Hepatol Endocrinol Diabetol &, Fulda, Germany
Bokemeyer, B:
Univ Hosp Schleswig Holstein, Gastroenterol Practice Minden, Clin Internal Med 1, Campus Kiel, Kiel, Germany
Univ Hosp Schleswig Holstein, Clin Internal Med 1, Campus Kiel, Kiel, Germany
hybrid, Green Published
|